Search Results

The safe clinical practice of growth hormone(GH) replacement requires judgement of the overall GH status, however, there is no biological marker for this in adults. In addition, diverse actions of GH in healthy individuals render the assessment of optimal GH replacement difficult. As in other fields of clinical practice, strategies and protocols vary between centers, however, most physicians experienced in pituitary diseases agree that GH replacement should begin at low doses, and increased to the final maintenance dose. The adequacy replacement is best determined by combination of clinical response and serum IGF-I, level avoiding supraphysiological levels of this GH-dependent peptide. Actually, GH can reduce body fat and restore muscles, bones, and quality of life. Appropriate using of GH will elicit antiaging effects.
Adipose Tissue ; Adult ; Biomarkers ; Growth Hormone* ; Humans ; Insulin-Like Growth Factor I ; Muscles ; Osteoporosis ; Pituitary Diseases ; Quality of Life

1.Appropriate Operation Extent.

2.Quit smoking strategies in primary care.

3.Clinical Study of Childhood Aplastic Anemia.

4.Growth Hormone Therapy in Adult Growth Hormone Defficiency.

5.Neurodevelopmental aspects of cerebral palsy.

6.Insulin-like growth factor I gene.

7.Growth Hormone Therapy.

8.Diagnosis and Treatment of Headache.

9.New drugs in the treatment of heart failure.

10.Expression of Somatostat in Receptor in GH-Producing Pituitary to Adenoma.

Display Mode

Output Records

File Type